The effect of Rosuvastatin on Carpal tunnel Syndrome
Phase 2
- Conditions
- Carpal tunnel syndrome (CTS).Carpal tunnel syndrome
- Registration Number
- IRCT2017022732799N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion criterion:
Patients with mild to moderate clinical symptoms and electrodiagnostic features of CTS.
Exclusion criteria: patients who have a history of taking statins; history of previous surgery for CTS; patients with severe CTS with muscle atrophy; extreme sensitivity to statins.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Median nerve motor and sensory distal latency. Timepoint: 1 month(interval between the onset of treatment determines the outcome of the study). Method of measurement: nerve conduction study.;Symptom severity and functional status of the patient. Timepoint: 1 month. Method of measurement: According to Boston Questionnaire.;Severity of pain. Timepoint: 1 month. Method of measurement: Visual Analogue Scale (VAS).
- Secondary Outcome Measures
Name Time Method Patients' function. Timepoint: 1. Method of measurement: Boston Questionnaire.